Varian Medical Systems Inc. (NYSE:VAR) CFO Elisha W. Finney sold 4,668 shares of the business’s stock in a transaction that occurred on Monday, October 3rd. The stock was sold at an average price of $98.87, for a total transaction of $461,525.16. Following the sale, the chief financial officer now owns 9,863 shares of the company’s stock, valued at approximately $975,154.81. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Varian Medical Systems Inc. (NYSE:VAR) opened at 99.11 on Thursday. The firm has a market capitalization of $9.25 billion, a PE ratio of 25.15 and a beta of 0.71. Varian Medical Systems Inc. has a 52 week low of $73.18 and a 52 week high of $100.07. The firm has a 50-day moving average of $96.50 and a 200 day moving average of $87.57.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, July 27th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.17 by $0.05. Varian Medical Systems had a net margin of 12.28% and a return on equity of 25.01%. The company earned $789.40 million during the quarter, compared to the consensus estimate of $779.90 million. During the same quarter last year, the company earned $1.15 earnings per share. Varian Medical Systems’s revenue for the quarter was up .7% on a year-over-year basis. Analysts predict that Varian Medical Systems Inc. will post $4.64 earnings per share for the current year.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Several hedge funds have recently added to or reduced their stakes in the company. Geode Capital Management LLC increased its stake in Varian Medical Systems by 3.3% in the first quarter. Geode Capital Management LLC now owns 874,988 shares of the company’s stock worth $69,892,000 after buying an additional 28,339 shares during the last quarter. Prudential PLC increased its stake in Varian Medical Systems by 14.5% in the first quarter. Prudential PLC now owns 16,600 shares of the company’s stock worth $1,328,000 after buying an additional 2,100 shares during the last quarter. British Columbia Investment Management Corp increased its stake in Varian Medical Systems by 49.5% in the second quarter. British Columbia Investment Management Corp now owns 68,828 shares of the company’s stock worth $5,660,000 after buying an additional 22,791 shares during the last quarter. Oakbrook Investments LLC bought a new stake in Varian Medical Systems during the second quarter worth $17,309,000. Finally, Speece Thorson Capital Group Inc. increased its stake in Varian Medical Systems by 1.4% in the second quarter. Speece Thorson Capital Group Inc. now owns 179,513 shares of the company’s stock worth $14,761,000 after buying an additional 2,415 shares during the last quarter. 99.65% of the stock is owned by institutional investors and hedge funds.

Several analysts recently commented on the stock. Jefferies Group reiterated a “buy” rating and issued a $98.00 price target on shares of Varian Medical Systems in a research report on Wednesday, September 28th. Robert W. Baird upped their price target on shares of Varian Medical Systems from $91.00 to $99.00 and gave the company a “neutral” rating in a research report on Wednesday, September 28th. Zacks Investment Research upgraded shares of Varian Medical Systems from a “hold” rating to a “buy” rating and set a $109.00 price target for the company in a research report on Tuesday, September 27th. Barrington Research reduced their price target on shares of Varian Medical Systems from $102.00 to $93.00 and set an “outperform” rating for the company in a research report on Thursday, July 28th. Finally, Morgan Stanley upped their price target on shares of Varian Medical Systems from $80.00 to $86.00 and gave the company an “underweight” rating in a research report on Thursday, July 28th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and four have issued a buy rating to the company’s stock. Varian Medical Systems presently has an average rating of “Hold” and a consensus price target of $91.33.

About Varian Medical Systems

Varian Medical Systems Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection.

5 Day Chart for NYSE:VAR

Receive News & Stock Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related stocks with our FREE daily email newsletter.